Britain's biggest drug maker has told Sky News it rejects claims by Chinese authorities that it offered bribes to doctors and hospitals.
GlaxoSmithKline (GSK) had been accused by China's Public Security Bureau (PSB) of offering free travel as "large bribes".
It said the bribes were "to open new sales channels and increase drug revenues" and given to doctors, hospitals, foundations and medical associations.
In a statement to Sky News, GSK said: "We take all allegations of bribery and corruption seriously. We continuously monitor our businesses to ensure they meet our strict compliance procedures
"We have done this in China and found no evidence of bribery or corruption of doctors or government officials."
It added: "We are aware of the statement from the PSB. We are willing to co-operate with the authorities in this inquiry.
"But this is the first official communication GSK has received from the PSB in relation to the specific nature of its investigation."
The Chinese authorities allegedly identified employees only as "high officials" but gave no details of the size of payments or who received them.
Sky News Asia Correspondent Mark Stone, reporting from Beijing, said: "What we don't know is if the accused are British nationals or Chinese nationals.
"Last week police in a city in south-central China said they were investigating high level Chinese staff."
It said the investigation took place in Shanghai and the cities of Changsha and Zhengzhou.
"After questioning, the suspects confessed to the crime," the PSB statement alleged.
Police in Changsha announced two weeks ago that GSK employees had been detained for questioning about unspecified "economic crimes".
The company said at that time it was co-operating but did not know what authorities were investigating.
Brentford-based GSK said in June that it had investigated an accusation that its salespeople in China bribed doctors and found no evidence of wrongdoing.
Last week Chinese state media reported that the government was investigating production costs for 60 foreign and domestic drug companies in a possible first step toward changing state-set maximum prices.
The announcement gave no indication any companies were suspected of wrongdoing.
:: In early Thursday trading in London, shares in GSK remained virtually flat against a buoyant market.
Anda sedang membaca artikel tentang
GlaxoSmithKline Denies China Drug Bribes
Dengan url
http://temannyakawanya.blogspot.com/2013/07/glaxosmithkline-denies-china-drug-bribes.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
GlaxoSmithKline Denies China Drug Bribes
namun jangan lupa untuk meletakkan link
GlaxoSmithKline Denies China Drug Bribes
sebagai sumbernya
0 komentar:
Posting Komentar